Skip to main navigation Skip to search Skip to main content

Hemolytic uremic syndrome following Campath-1H induction

  • Hugo Bonatti
  • , Gerald Brandacher
  • , Claudia Boesmueller
  • , Micol Cont
  • , Paul Hengster
  • , Alexander R. Rosenkranz
  • , Jens Krugmann
  • , Raimund Margreiter

Research output: Contribution to journalArticlepeer-review

Abstract

Hemolytic uremic syndrome (HUS) is a rare complication following solid organ transplantation. We report on a patient who underwent renal transplantation using Campath-1H induction and tacrolimus maintenance therapy who developed HUS, which was managed by plasma exchange and switch to Rapamycin. However, graft function could not be restored.

Original languageEnglish (US)
Pages (from-to)386-389
Number of pages4
JournalTransplant International
Volume20
Issue number4
DOIs
StatePublished - Apr 2007
Externally publishedYes

Keywords

  • Campath-1H
  • Haemolytic uremic syndrome
  • Rapamycin
  • Renal transplantation

ASJC Scopus subject areas

  • Transplantation

Fingerprint

Dive into the research topics of 'Hemolytic uremic syndrome following Campath-1H induction'. Together they form a unique fingerprint.

Cite this